Digital Healthcare Ltd - Medical Equipment - Deals and Alliances Profile

Digital Healthcare Ltd, (DHC) is an UK-based company that provides software solutions for eye screening and technology to manage information and images in clinical ophthalmology. The products offered by the company include, OptoMize Retinopathy Screening, the USed to detect early and previously undiagnosed signs of diabetic retinopathy and other causes of blindness, Retasure, the USed by diabetic patients for assessment of their retinal health and OcuLab, the USed in Ophthalmology Departments, to integrate clinical instruments and distribute information across their institutions. The solutions of DHC are namely, OptoMize, Diabetic Retinopathy Screening, OptoMize, Systematic Population Screening , NHS HealthChecks, OcuLab, Enterprise Ophthalmology and Retasure, Retinal Risk Assessment. DHC is headquartered in Cambridge, the UK.

Digital Healthcare Ltd - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

For more information visit : Digital Healthcare Ltd - Medical Equipment - Deals and Alliances Profile

Baylis Medical Company Inc. is a pharmaceuticals and healthcare company

Baylis Medical Company Inc. (Baylis Medical) is a pharmaceuticals and healthcare company, based in Canada. The company operates through its segments cardiology, vascular, pain management and interventional neurology. It develops, manufactures and markets medical products for the healthcare markets. Its products include Pain Management Products include Single use Probe Kits, transdiscal system, neurological Probes and datastream Data Recording Software. Cardiology Products include Baylis RF Pain Management System, Radio frequency Puncture Generator and BMC Pro Track Micro catheter. Radiology Products include RF Puncture System Accessories, Return Electrode and Footswitch. Baylis Medical products are utilized by cardiologists, interventional radiologists and electrophysiologists. The company distributes and markets its products through its brands RadiOpaque, DataStream, TransDiscal System, Baylis Integra, Torflex, PowerWire and ProTrack. It is ISO 13485:2003 certified company. Baylis Medical is headquartered in Quebec, Canada.

Baylis Medical Company Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

More information on Baylis Medical Company Inc.

Kane Biotech Inc. (Kane Biotech) is a biotechnology company

Kane Biotech Inc. (Kane Biotech) is a biotechnology company that develops and commercializes products to prevent and disperse microbial biofilms. The company utilizes patented technologies, namely, Aledex and DispersinB and competence stimulating peptide (CSP) signaling system, for the development the product candidates.  The Aledex pipeline products include the urinary catheter coating, venous catheter coating and veterinary catheter coating. DispersinB's product pipeline consists of wound gels, wound dressings, venous catheter coating and cystic fibrosis. CSP technology's product pipeline includes a novel mouthwash and toothpaste additive. Kne Biotech has partnership with Harland Medical Inc and Ward Biotech for the development of the product candidates. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.

Kane Biotech Inc. (KNE) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

More information on Kane Biotech Inc. (KNE) - Medical Equipment - Deals and Alliances Profile

Frost Group, LLC - Medical Equipment - Deals and Alliances Profile

Frost Group, LLC is a private investment firm. These investments include stakes in the areas of pharmaceuticals, diagnostic devices, medical devices, developmental education and entertainment for children, telecommunications, sports licensing, aviation services, software for seismic data analysis, and new materials for computer chips.

Frost Group, LLC - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.

For more information visit :  Frost Group, LLC - Medical Equipment

Swot Analysis Review of Kilitch Drugs (India) Ltd. (KILITCH) Compnay

Kilitch Drugs (India) Ltd. (Kilitch) is a publicly held pharmaceutical company engaged in manufacturing and marketing of various range of formulations in solid, liquid and parent forms. The company offers contract manufacturing service to national and multinational pharmaceutical companies. Kilitch has tie-ups with more than 20 leading pharmaceutical companies, including Ranbaxy Laboratories Limited, Sand India Limited, Merck Limited, Zydus Cadillac, Nicholas Primal India Limited, USV Limited and others for exports. It's product portfolio include carabineer, cephalosporin, beta, lactate antibiotics, steroids and hormones, gastro logy related drugs, NSAIDs, anti malarial, aminoglycosides and other anti-infectives. Flitch exports its products to Algeria, Burundi, Cameroon, Tanzania, Uganda, Eritrea, Russia, Senegal, Ghana, Iraq, Nigeria Lanka, Tchad, Niger, Ethiopia, Yemen, Sudan. It is specialized as a manufacturer of antibacterial parent formulations and as producers of sterile liquid formulations in small volumes. Kilitch is headquartered at Mumbling in Maharashtra, India.

This comprehensive SWOT profile of Kilitch Drugs (India) Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.

For more information visit :  Kilitch Drugs (India) Ltd. (KILITCH)

MetaStat, Inc. (MTST) - Product Pipeline Analysis

MetaStat, Inc., (MetaStat) formerly known as Photovoltaic Solar Cells Inc., is a life science company. It focuses on the development of proprietary clinical diagnostic tests. The company's product portfolio consists of MetaSite Breast, developed to predict the spread of cancer through the bloodstream to other organs; MenaCalc Lung, a test evaluated to predict the likelihood of metastasis in adenocarcinoma of the lung; MenaCalc Prostate, a diagnostic for prostate cancer; and MenaBloc, a platform technology that provides a target to develop therapies that can preemptively reduce or eliminate metastasis. It develops these products using mena protein, a potentiator and modulator of cellular migration. The company operates a wholly-owned subsidiary, namely, MetaStat BioMedical, Inc. MetaStat is headquartered in The Woodlands, Texas, the US.

This report is a source for data, analysis and actionable intelligence on the MetaStat, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

For more information on MetaStat, Inc. (MTST) - Product Pipeline Analysis.

MicroTransponder Inc. - Product Pipeline Analysis

MicroTransponder Inc. (MicroTransponder) is a medical device company. It is a spun out from the University of Texas. The company carries out the development of neurostimulation solutions to treat neurological diseases. The company offers systems for the treatment of various neurological diseases, including tinnitus, autism and post stroke motor rehabilitation. The company’s serenity system, which pairs an Vagus Nerve Stimulation, is used to treat over 60,000 patients for epilepsy and depression. MicroTransponder is headquartered in Dallas, Texas, the US.

The company’s continous focus on the neuroscience related to the condition of tinnitus helped it to develop a novel therapy. Recently, the company presented data from the initial 10-patient tinnitus clinical trial at the Tinnitus Research Initiative conference in Belgium.

This report is a source for data, analysis and actionable intelligence on the MicroTransponder Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.

For more information on MicroTransponder Inc. - Product Pipeline Analysis